Authors
Latest:
Advice for Managing Patients With PNShawn Kwatra, MD, and Sarina B. Elmariah, MD, PhD, share final pearls of wisdom for other physicians taking care of patients with prurigo nodularis (PN).
Latest:
A Year of RSV Highs and Lows, with Tina Tan, MDThe Contemporary Pediatrics Editor-in-Chief reviews the pharmacological breakthroughs and epidemiological setbacks that defined RSV in 2023.
Latest:
Novel Agents for the Management of Pediatric and Adult ADHDDrs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Latest:
Novel Investigational Approaches For the Treatment of Neovascular AMDDr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Latest:
Diabetes Dialogue: 2024 ACP Type 2 Diabetes RecommendationsIn this episode, hosts break down the latest type 2 diabetes recommendations from the American College of Physicians and offer their perspective on second-line therapies in T2D.
Latest:
Efficacy of Prescription Vs OTC Fish Oil ProductsWhat pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.
Latest:
Importance of Long-Term Data in Plaque PsoriasisLeon Kircik, MD, shares his impressions of the long-term data of roflumilast, and where it fits into clinical practice.
Latest:
Approaching Plaque Psoriasis Treatment in Difficult-to-Treat AreasAn expert in dermatology provides insight on approaching treatment in patients with plaque psoriasis who have a low BSA involvement, but with symptoms that present in difficult-to-treat areas.
Latest:
Emerging Agents for Heart Failure TreatmentJames Januzzi, MD, and Javed Butler, MD, MPH, MBA, discuss emerging agents, vericiguat and intravenous (IV) iron, in the treatment landscape for heart failure with reduced ejection fraction and advice for community physicians managing patients with heart failure.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Will Tirzepatide Finally Turn the Tide in Access to Obesity Treatment?In this column, Katherine Saunders, MD, of Weill Cornell Medicine, provides perspective on the approval of tirzepatide for chronic weight management and what it might mean for patient access in the future.
Latest:
Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National DatabaseA history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
Latest:
Endocrine Case Report: Hip PainThis endocrine case report from Brady Pregerson, MD, features a man in his 40s with a history of T1D presenting with waxing and waning right groin and inner thigh pain. Can you determine the proper diagnosis?
Latest:
How Do I Reduce My Blue Light Intake?An ophthalmologist provides insight into the harms of excessive blue light, and simple consumer resolutions.
Latest:
SUNSHINE and SUNRISE Trials in HSAn expert in dermatology reviews the phase 3 SUNSHINE and SUNRISE trials evaluating the use of secukinumab given in 2-week intervals in patients with HS and shares clinical pearls for managing the condition.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns to biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
Impact of Diagnosis Delay on Long Term Lupus OutcomesDrs. Anne E. Winkler and Kristi V. Mizelle discuss the negative long term disease outcomes noted in patients who experience a delay in their lupus diagnosis.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns to biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
Monitoring Treatment Response in Treat-to-Target in CDExperts continue the discussion on treat-to-target in CD, highlighting monitoring treatment response.
Latest:
Untapped Potentials - Exploring Overlooked Therapies for Type 2 DiabetesIn this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.
Latest:
Anticipated Developments in the Field of Plaque PsoriasisMatthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.
